Although increased Alb is a known biomarker of CKD progression and has been used in other clinical tools for predicting progressive CKD [9], Alb has been observed as being less accurate when predicting CKD progression in early eGFR categories than more advanced categories in addition to patients with advanced eGFR categories having normoalbuminuria [16,41]. The gene discussed is ALB; the disease is chronic kidney disease.